| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
|
Sonneveld, Pieter
|
|
|
23 |
9 |
p. 687-696
|
artikel
|
| 2 |
Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study
|
Zhuang, Tony Zibo
|
|
|
23 |
9 |
p. 667-673
|
artikel
|
| 3 |
Comparison of Inpatient Outcomes Between HIV Positive and Negative Hospitalizations for Autologous Stem Cell Transplant Treatment among Lymphoid Malignancies
|
Ruiz, Marco
|
|
|
23 |
9 |
p. e307-e313
|
artikel
|
| 4 |
Culturally Responsive Care Delivery in Oncology: The Example of Multiple Myeloma
|
Blue, Brandon
|
|
|
23 |
9 |
p. 651-659
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
23 |
9 |
p. A4-A5
|
artikel
|
| 6 |
External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse
|
Boyne, Devon J.
|
|
|
23 |
9 |
p. e277-e285
|
artikel
|
| 7 |
Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma Population
|
Thapa, Kriti
|
|
|
23 |
9 |
p. e260-e267
|
artikel
|
| 8 |
Olverembatinib Treatment in Pediatric Patients With Relapsed Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia
|
Li, Xiaolan
|
|
|
23 |
9 |
p. 660-666
|
artikel
|
| 9 |
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies
|
Patel, Manish R.
|
|
|
23 |
9 |
p. 674-686
|
artikel
|
| 10 |
Plasmablastic Lymphoma: Past, Present, and Future
|
Kaur, Supreet
|
|
|
23 |
9 |
p. e253-e259
|
artikel
|
| 11 |
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis
|
Manier, Salomon
|
|
|
23 |
9 |
p. e297-e306.e1
|
artikel
|
| 12 |
Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma
|
Mei, Matthew
|
|
|
23 |
9 |
p. e268-e276
|
artikel
|
| 13 |
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies
|
Schiller, Gary J.
|
|
|
23 |
9 |
p. e286-e296.e4
|
artikel
|
| 14 |
SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas
|
Bhansali, Rahul S.
|
|
|
23 |
9 |
p. 642-650
|
artikel
|
| 15 |
SOHO State of the Art Updates and Next Questions: Tailoring Upfront Therapy in Mantle Cell Lymphoma
|
Patel, Dilan
|
|
|
23 |
9 |
p. 633-641
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
23 |
9 |
p. A6-A8
|
artikel
|
Tijdschrift beschrijving